In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $18.17 in the prior trading day, Neogenomics Inc (NASDAQ: NEO) closed at $17.90, down -1.49%. In other words, the price has decreased by -$1.49 from its previous closing price. On the day, 0.6 million shares were traded. NEO stock price reached its highest trading level at $18.475 during the session, while it also had its lowest trading level at $17.86.
Ratios:
Our goal is to gain a better understanding of NEO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.91 and its Current Ratio is at 1.99. In the meantime, Its Debt-to-Equity ratio is 0.67 whereas as Long-Term Debt/Eq ratio is at 0.44.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on December 10, 2024, initiated with a Buy rating and assigned the stock a target price of $22.
BTIG Research reiterated its Buy rating for the stock on December 29, 2023, while the target price for the stock was revised from $25 to $21.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 15 ’24 when Olivo Alicia C sold 5,175 shares for $15.36 per share. The transaction valued at 79,475 led to the insider holds 37,129 shares of the business.
ALICIA OLIVO bought 5,175 shares of NEO for $81,713 on Nov 15 ’24. On Aug 15 ’24, another insider, Olivo Alicia C, who serves as the General Counsel of the company, sold 1,040 shares for $16.05 each. As a result, the insider received 16,695 and left with 43,813 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NEO now has a Market Capitalization of 2332316160 and an Enterprise Value of 2516114688. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.57 while its Price-to-Book (P/B) ratio in mrq is 2.52. Its current Enterprise Value per Revenue stands at 3.906 whereas that against EBITDA is -5628.892.
Stock Price History:
Over the past 52 weeks, NEO has reached a high of $21.22, while it has fallen to a 52-week low of $12.77. The 50-Day Moving Average of the stock is 17.45%, while the 200-Day Moving Average is calculated to be 19.01%.
Shares Statistics:
The stock has traded on average 752.68K shares per day over the past 3-months and 536200 shares per day over the last 10 days, according to various share statistics. A total of 128.06M shares are outstanding, with a floating share count of 126.83M. Insiders hold about 1.20% of the company’s shares, while institutions hold 97.50% stake in the company. Shares short for NEO as of 1732838400 were 3686439 with a Short Ratio of 4.90, compared to 1730332800 on 4235756. Therefore, it implies a Short% of Shares Outstanding of 3686439 and a Short% of Float of 3.9899999999999998.
